Gapping up
In reaction to strong earnings/guidance:
- NTRI +19.4%, PAH +5.6%, KND +5.1%, BWXT +5%, FRO +4.8%, USCR +4.7%, IONS +4.5%, GOGL +4.4%, TCMD +4.3%
- PCLN +4.2%, NRG +4.2%, AMRN +4.1%, ICD +3.7%, ANTH +3%, ESV +2.8%, DPZ +2.7%, HTZ +2%, WUBA +2%, HSKA +1.9%
- NLNK +1.9%, EOG +1.6%, ALB +1.5%, GAIA +1.2%, SGMO +1%
M&A news:
- SBY +17.9% (Silver Bay Realty Trust agrees to be acquired for $21.50 per share in cash)
Select metals/mining stocks trading higher:
- SBGL +2.1%, GOLD +1.7%, GFI +1.7%, AKS +1.2%, AU +1%, GDX +1%, NEM +0.9%
Other news:
- ROX +45.2% (announces an agreement to supply Goslings Stormy Ginger Beer and Goslings Stormy Diet Ginger Beer to all U.S. Walmart (WMT) stores)
- NSPR +15.4% (continued strength), INUV +13.5% (Inuvo's Vertro and Google entered into a Google Services Agreement)
- LIFE +10.1% (announces that its product candidate Resolaris was granted Orphan Drug Designation by the FDA for the treatment of limb girdle muscular dystrophy patients)
- DRYS +8.6% (to initiate a new dividend policy; will pay a regular fixed quarterly dividend of $2.5 million to the holders of common stock)
- CANF +7.7% (announces new data that 'show its liver disease drug candidate Namodenoson (CF102) prevented liver (hepatic) fibrosis progression in preclinical studies)
- AMD +1.1% (continued strength)
Analyst comments:
- DRRX +2.9% (resumed with a Buy at H.C. Wainwright)
- X +2.8% (upgraded to Outperform from Market Perform at Cowen)
- CSX +1.7% (upgraded to Buy from Hold at Deutsche Bank)
- AYR +1.3% (upgraded to Neutral from Underperform at BofA/Merrill)